Ginkgo Bioworks Holdings, Inc. (DNA)

Ginkgo Bioworks Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	143.86	167.2	561.57	944.07	1,316	1,550
Short-Term Investments	229.59	255.42	-	-	-	-
Cash & Short-Term Investments	373.46	422.62	561.57	944.07	1,316	1,550
Cash Growth	-27.75%	-24.74%	-40.52%	-28.25%	-15.11%	307.04%
Accounts Receivable	20.27	24.26	22.44	17.9	82.47	136.14
Inventory	-	-	-	-	-	3.36
Other Current Assets	16.23	24.96	18.73	39.78	51.82	33.54
Total Current Assets	409.96	471.84	602.74	1,002	1,450	1,723
Net Property, Plant & Equipment	516.82	528.29	598.16	394.99	715.54	145.77
Other Intangible Assets	48.86	53.48	72.51	82.74	111.04	21.64
Goodwill	-	-	-	49.24	60.21	21.31
Long-Term Investments	-	-	-	78.57	113.73	115.23
Other Long-Term Assets	42.73	51.02	55.34	58.06	88.73	43.99
Total Assets	1,033	1,120	1,377	1,665	2,539	2,071
Accounts Payable	16.31	10.57	14.17	9.32	10.45	8.19
Accrued Expenses	48.38	66.46	65.39	110.05	114.69	93.33
Unearned Revenue	14.91	18.95	27.71	44.49	47.82	33.24
Total Current Liabilities	79.6	95.97	107.27	163.86	172.96	134.76
Long-Term Leases	410.7	417.08	438.77	221.84	413.26	22.28
Other Long-Term Liabilities	99.63	98.06	115.36	182.5	216.83	346.57
Total Long-Term Liabilities	510.33	515.14	554.13	404.33	630.08	368.85
Total Liabilities	589.92	611.11	661.39	568.19	803.04	503.61
Common Stock	0.01	0.01	0.01	0.01	0.19	0.16
Additional Paid-in Capital	6,675	6,657	6,555	6,386	6,136	3,805
Accumulated Other Comprehensive Income	1.19	1.85	-1.81	1.48	-2.63	-1.72
Retained Earnings	-6,233	-6,150	-5,838	-5,291	-4,398	-2,298
Total Common Shareholders' Equity	443.15	508.59	716.06	1,097	1,736	1,505
Minority Interest	-	-	-	-	-	62.01
Shareholders' Equity	443.15	508.59	716.06	1,097	1,736	1,567
Total Liabilities & Equity	1,033	1,120	1,377	1,665	2,539	2,071
Total Debt	410.7	417.08	438.77	221.84	413.26	22.28
Net Cash (Debt)	-37.24	5.54	122.81	722.24	902.54	1,528
Net Cash Growth	-	-95.49%	-83.00%	-19.98%	-40.92%	319.38%
Net Cash Per Share	-0.66	0.10	2.37	14.86	21.49	44.92
Book Value	443.15	508.59	716.06	1,097	1,736	1,505
Book Value Per Share	7.80	9.17	13.80	22.57	41.34	44.26
Tangible Book Value	394.29	455.11	643.55	965.17	1,565	1,462
Tangible Book Value Per Share	6.94	8.21	12.40	19.86	37.27	43.00

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q